VCNDD applies an academic understanding of neuroscience to the drug discovery process, thus pioneering a new model in academic drug discovery. Specialized teams of medicinal chemists, pharmacologists, and pharmacokineticists develop novel compounds with enhanced selectivity, efficacy, and in vivo safety profiles that are ready for clinical testing. VCNDD expertise includes early target validation, discovery efforts, lead
optimization, and preclinical candidates.
Areas of focus include:
- Parkinson’s
- Fragile X/autism
- Schizophrenia
- Alzheimer’s
Focus area:
Neuroscience and Drug Discovery
Url:
www.vcndd.com